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Summary We report the epidemiological and clinical characteristics of the erysipeloid form
of cutaneous leishmaniasis as well as its diagnostic and therapeutic challenges.
Case report: A 63-year-old woman, with no medical history, presented with a one-month history
of erythematous nasal swelling. The lesion appeared after an accidental trauma. Erythematous
inﬁltrative plaque was noted on the center of the face. There were also crust formations on the
traumatic region. Despite local treatment and oral antibiotherapy, there was no improvement.
The diagnosis of cutaneous leishmaniasis was conﬁrmed by positive skin smears. Histopathologi-
cal examinations of a skin biopsy showed nomalignancy. The patient was treated intramuscularly
with 10mg/kg per day systemic meglumine antimoniate with partial regression of symptoms.
Conclusion: The erysipeloid type is a rare and unusual presentation of cutaneous leishmaniasis
that often causes late diagnosis. Diagnosis is conﬁrmed by the demonstration of the parasite
by skin smear, histopathological examination and polymerase chain reaction. There are various
therapeutic options. The evolution is generally favourable.
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Introduction
Cutaneous leishmaniasis (CL) is a world widespread parasitic
disease caused by the infectious bite of an insect vector, the
phlebotomine sandﬂy. In Tunisia, it has become a very com-
mon disease for several years, with an endemo-epidemic
mode of evolution. Leishmania major is by far the most fre-
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uent parasite encountered in Southern parts of the country
1]. Cutaneous leihmaniasis is characterized by clinical poly-
orphism. Erysipeloid form is a rare and unusual entity.
We report a case of erysipeloid form of CL of the
ace in order to examine the epidemiological, clinical and
herapeutical features of this form.bservation
63-year-old female patient had no particular past-medical
istory. She consulted for a one-month inﬂammatory nasal
welling that occurred after nasal trauma. Pristinamycine
served.
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oigure 1 Erythemateous inﬁltrative plaque asymmetrically
overing the center of the face.
as administered orally for 7 days without clinical improve-
ent. Physical examination revealed an erythematous
nﬁltrative plaque covering the center of the face (nose and
heeks) with a grossly symmetrical pattern of 5 cm lesions
overed by places with crusts (Fig. 1). Endonasal exami-
ation did not reveal any mucosal lesion and the rest of
he examination was normal. The patient was apyretic and
he biological and inﬂammatory evaluation tests were nor-
al. The patient was admitted to hospital and received
road spectrum antibiotic treatment with daily local care
n prevention of post-traumatic cellulitis risk. Evolution
as marked by the absence of clinical improvement with
tendency to spreading of erythematous lesions (Fig. 2).
iopsy of the lesion did not reveal any sign of malignancy.
t that stage, CL was suspected and conﬁrmed by posi-
ive nasal tissue smears, which demonstrated leishmania
mastigotes forms. A treatment with 10mg/kg per day sys-
igure 2 Erysipeloid cutaneous leishmaniasis of the face:
preading of the lesions after antibiotic treatment.
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emic meglumine antimoniate (Glucantime®) administered
ntramuscularly was conducted. The evolution was marked
y partial healing of the lesions.
iscussion
n Tunisia, the classic form of CL is nodular with ulcers and
rusts. The manifestation is an inﬁltrative nodule with a
entral crater covered with a yellow brownish crust. Spon-
aneous healing occurs within a few months with ﬁlling
f ulcer, leaving a clear or pigmented scar and conferring
asting immunity [1]. Cases of CL in its erysipeloid form
ave been reported in Iran, Pakistan, Turkey and Tunisia
1—4]. It differs from the other forms by its clinical fea-
ures but also by the predominantly affected population
4].
In the literature, the incidence rate of erysipeloid form
f CL ranges between 0,05 and 3,2% [1,3]. This type pre-
ominantly affects elderly females [4]. Clinical features are
rythematous inﬁltrative ill-deﬁned plaque over the face
overing the nose and both cheeks [1].
The etiology of this type is unknown. Altered host
mmune response due to senility, a speciﬁc type of parasite,
ormonal changes at menopause, skin quality alteration
ue to ageing were evoked to explain this particular form
1,2,4]. Post-traumatic cutaneous lesions can facilitate the
ccurrence of this type of disease [5].
Our patient presented with all the epidemiological fea-
ures characterizing this particular form. She was native of
n endemic region of leishmaniasis, of old age, menopaused
ith a history of nasal trauma followed by the occurrence
f the nasal lesion.
In cases of localized form, these lesions can evoke bac-
erial or fungal skin infection, syphilis, anthrax, eczema,
uberculosis, infected insect bite or primary or metastatic
kin tumor. In cases of facial lesions, differential diag-
osis must be made with disseminated or discoid lupus
rythematous, lupus vulgaris, sarcoidosis or erysipelas
4,6].
In Tunisia, CL diagnosis is based on direct parasitology
ests to detect leishmania parasites, DNA research of leih-
aniases via PCR (a new technique recently used in Tunisia)
nd on the histopathological examination of skin biopsy [7].
There are several therapeutic options such as cryother-
py, heat therapy with radiofrequency, topical treatment,
ral treatments such as ﬂuconazole, metronidazole [8]. In
unisia, the pentavalent antimony (meﬂumine antimoni-
te) remains the treatment mainstay. Parenteral antimony
dministration is used with a 10mg/kg per day dosage twice
aily for 20 days [6]. Parenteral administration is recom-
ended in cases of multiple or severe lesions or in lesions
ausing severe cosmetic sequelae on the face, for exam-
le. Erysipeloid form involving the face requires injectable
reatment as in the case of our patient.
A treatment with topical herbal extract (Z-HE) was
escribed by Zerehsaz and al [9] in this particular form
f disease with a healing rate without recurrence of 92%
fter 12-month follow-up. Low cost, easy preparation and
ew drug related side effects characterize this topical treat-
ent but further studies are necessary in order to conﬁrm
ts efﬁciency.
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Evolution is usually less than a year without major aes-
thetic sequelae [1,4].
Conclusion
CL of the face can have various clinical presentations.
Any dermatologist and ENT specialist has to think of it
when examining any unusual lesion of the face looking like
erysipelas especially in subjects living or having stayed in
endemic region of CL.
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